![Louise Rodino-Klapac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 980 515 $ per 2026-06-30
Dr. Louise Rodino-Klapac is a President-Research & Development at Sarepta Therapeutics, Inc., a Member at American Academy of Neurology and a Member at American Society of Gene & Cell Therapy.
She is on the Board of Directors at Alliance for Regenerative Medicine.
Dr. Rodino-Klapac was previously employed as a Chief Scientific Officer by Myonexus Therapeutics, Inc. and a Head-Gene Therapy Research Laboratory by Nationwide Children's Hospital.
She also served on the board at AavantiBio, Inc. She received her undergraduate degree from King's College (Pennsylvania) and a doctorate degree from The Ohio State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-08 | 54 564 ( 0,05 % ) | 980 515 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2020-12-14 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direktör/Styrelseledamot | 2021-01-01 |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Företagsledare/Principal | - |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
Nationwide Children's Hospital
 Nationwide Children's Hospital Hospital/Nursing ManagementHealth Services Operates children's hospitals | Företagsledare/Principal | 2019-06-01 |
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for limb-girdle muscular dystrophies | Grundare | 2019-04-01 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Direktör/Styrelseledamot | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
King's College (Pennsylvania)
 King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Nationwide Children's Hospital
Nationwide Children's Hospital Hospital/Nursing ManagementHealth Services Operates children's hospitals | Health Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for limb-girdle muscular dystrophies | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
